News Roche drug too pricey in progressive MS, says NICE Ocrevus is effective but too pricey in PPMS, says NICE
News Industry urges EU to scrap national HTA bodies Influential EU committee discusses proposals today
News NICE says 'no' to Roche's Perjeta after breast cancer surger... NICE consulting on first draft decision
News Patients call for end to two-year row over CF drug funding UK patients are stepping up efforts to resolve the “heartbreaking” row that is denying their families access to Vertex’s groundbreaking cystic fibrosis (CF) drug Orkambi, after Sweden becam
News J&J's Tremfya gets funding in Germany and UK Johnson & Johnson’s psoriasis drug Tremfya has been given the green light for funding by cost-effectiveness bodies in the UK and Germany.
News Dexcom is first to join FDA/CMS health tech pilot The FDA has named Dexcom as the first company to take part in its TEMPO pilot, which aims to bring digital health tech to patients more quickly.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
